Introduction:
Stevanato Group plans to open new manufacuting facility in North America. The new facility will provide an additional supply source for its mission critical products.
Features:
The new plant will be designed with an area covering 370,000 square feet and will be used for the production of Stevanato Group’s EZ-Fill® solutions, pre-sterilized drug containment systems for pharmaceutical use.
The new state-of-the-art facility features new production lines equipped with advanced process technologies to produce EZ-Fill® syringes and vials.
Moreover, the new facility serves as a center to support customers to provide technical support as maintenance for visual inspection, assembly and packaging equipment.
The new manufacturing site will be fully opeartional by 2023. After the completion of the new facility, it is expected to create 230 new local employees for the production, engineering and maintenance, as well as other corporate support positions.
Specifications:
| Name | Stevanato Group |
| Type | New Construction |
| Budget | US$145 million |
| Year | 2023 |
